Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Assets Average (2011 - 2026)

Vericel (VCEL) posted Assets Average of $494.2 million for Q2 2026, up 1.53% sequentially from $486.8 million in Q1 2026, and up 14.91% YoY from $430.1 million in Q2 2025.

Analysis

Vericel (VCEL) Assets Average (2011 - 2026) Analysis & Trends

Vericel has reported Assets Average for 16 years, with the latest figure at $494.2 million in Q2 2026.

  • Quarterly Assets Average rose 14.91% year-over-year to $494.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $494.2 million (up 14.91% YoY) and the FY2025 annual result came in at $460.3 million, up 17.08% from the prior year.
  • Assets Average improved to $494.2 million in Q2 2026 per VCEL's latest filing, from $486.8 million in the prior quarter.
  • Over five years, Assets Average peaked at $494.2 million in Q2 2026 and troughed at $242.0 million in Q1 2022.
  • A 5-year average of $359.5 million and a median of $361.0 million in 2024 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2022 and 2024: Assets Average climbed 10.48% in 2022, then jumped 32.01% in 2024.
  • Over 5 years, Assets Average stood at $260.5 million in 2022, then climbed by 28.94% to $335.9 million in 2023, then gained by 22.53% to $411.6 million in 2024, then grew by 14.35% to $470.6 million in 2025, then grew by 5.02% to $494.2 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $494.2 million, $486.8 million, and $470.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 3.29 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.09 Bn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 494.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 494.25 Mn
Mar 31, 2026 486.80 Mn
Dec 31, 2025 470.62 Mn
Sep 30, 2025 444.44 Mn
Jun 30, 2025 430.10 Mn
Mar 31, 2025 428.65 Mn
Dec 31, 2024 411.56 Mn
Sep 30, 2024 383.62 Mn
Jun 30, 2024 366.75 Mn
Mar 31, 2024 355.16 Mn
Dec 31, 2023 335.89 Mn
Sep 30, 2023 314.42 Mn
Jun 30, 2023 287.90 Mn
Mar 31, 2023 269.05 Mn
Dec 31, 2022 260.51 Mn
Sep 30, 2022 246.42 Mn
Jun 30, 2022 242.55 Mn
Mar 31, 2022 242.00 Mn
Dec 31, 2021 233.92 Mn
Sep 30, 2021 223.04 Mn